Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects.
Saved in:
| Title: | Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects. |
|---|---|
| Authors: | Ladak R; Schulich School of Medicine and Dentistry, Western University, London, CAN., Fifield BA; Department of Biomedical Sciences, University of Windsor, Windsor, CAN., Porter L; Department of Biomedical Sciences, University of Windsor, Windsor, CAN., Hirmiz K; Department of Radiation Oncology, Windsor Regional Hospital, Windsor, CAN., Hamm C; Department of Medical Oncology, Windsor Regional Hospital, Windsor, CAN. |
| Source: | Cureus [Cureus] 2024 Sep 03; Vol. 16 (9), pp. e68576. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.68576 |
